Fate Therapeutics, Inc. (NASDAQ:FATE) Short Interest Update
Fate Therapeutics, Inc. (NASDAQ:FATE – Get Free Report) was the recipient of a significant growth in short interest in October. As of October 15th, there was short interest totalling 16,060,000 shares, a growth of 13.3% from the September 30th total of 14,180,000 shares. Based on an average daily volume of 1,320,000 shares, the short-interest ratio […]
31 Oct 22:44 · The Markets Daily